Long-Term Outcomes in Autosomal Recessive Hypophosphatemia Due to DMP1 Mutation
Author Information
Author(s): Mäkitie Outi, Pereira Renata C, Kaitila Ilkka, Turan Serap, Bastepe Murat, Laine Tero, Kröger Heikki, Cole William G, Jüppner Harald
Primary Institution: Hospital for Children and Adolescents, University of Helsinki
Hypothesis
The study investigates the clinical outcomes and carrier phenotypes associated with a novel DMP1 mutation causing autosomal recessive hypophosphatemia.
Conclusion
The homozygous DMP1 mutation leads to severe skeletal dysplasia and hypophosphatemia, while heterozygous carriers exhibit mild hypophosphatemia without significant skeletal issues.
Supporting Evidence
- Homozygous DMP1 mutations result in severe skeletal dysplasia and hypophosphatemia.
- Both affected individuals experienced significant joint pain and immobilization.
- Radiographic findings showed short and deformed long bones and cranial hyperostosis.
- Heterozygous carriers exhibited mild hypophosphatemia without skeletal deformities.
Takeaway
This study looks at a family with a rare genetic condition that affects their bones and how a specific gene mutation causes these problems.
Methodology
Clinical data were collected from medical records, and blood and urine samples were analyzed for calcium and phosphorus levels, along with bone metabolism markers.
Limitations
The study is limited by the small sample size and the specific family context, which may not represent the broader population.
Participant Demographics
Two affected adult siblings (one male, one female) and two healthy children who are heterozygous carriers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website